Dr. Sanka and Dr. Singh discuss minimally invasive glaucoma surgery, highlighting how it enhances glaucoma management, reduces medication reliance, and improves patient quality of life.

Explore the shift in glaucoma and cataract treatment recommendations by eye care specialists Dr. I. Paul Singh and Dr. Sanka, prioritizing early intervention for better patient outcomes.

Avisi Technologies has announced a successful $10.7 million funding round aimed at developing its innovative glaucoma treatment device, VisiPlate®.

Avisi Technologies celebrates FDA approval for the VisiPlate® clinical trial, aiming to revolutionize glaucoma treatments with an innovative aqueous shunt.

Barnet Dulaney Perkins introduces iDose® TR, a groundbreaking implant designed to treat glaucoma efficiently, reducing dependency on eye drops.

The Glaucoma Treatment Devices Market is expected to expand significantly, from USD 4.5 billion in 2024 to USD 7.2 billion by 2033, driven by innovative surgical technologies.

Palatin Technologies has introduced encouraging preclinical findings for its melanocortin agonist PL9588, aiming to transform glaucoma treatment with dual benefits.

Sanoculis Ltd. has obtained CE Mark approval for its innovative MINT® device, aimed at providing effective treatment for glaucoma patients with a less invasive approach.